FDA Calls Medtronic, Inc. Drug Pump Warning Class I
LOS ANGELES (Reuters) - Medtronic Inc said on Wednesday that U.S. regulators classified its move to inform physicians about an increase in the rate of inflammatory mass cases in patients receiving drugs through the company's implantable infusion pumps as a Class I recall.